loadpatents
name:-0.007375955581665
name:-0.0083861351013184
name:-0.0039770603179932
BAUMEISTER; Hans Patent Filings

BAUMEISTER; Hans

Patent Applications and Registrations

Patent applications and USPTO patent grants for BAUMEISTER; Hans.The latest application filed is for "use of human cells of myeloid leukaemia origin for expression of antibodies".

Company Profile
3.8.6
  • BAUMEISTER; Hans - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies
App 20190359731 - GOLETZ; Steffen ;   et al.
2019-11-28
Use of human cells of myeloid leukemia origin for expression of antibodies
Grant 10,280,230 - Goletz , et al.
2019-05-07
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies
App 20150368363 - GOLETZ; Steffen ;   et al.
2015-12-24
Use of human cells of myeloid leukaemia origin for expression of antibodies
Grant 9,051,356 - Goletz , et al. June 9, 2
2015-06-09
Highly active glycoproteins-process conditions and an efficient method for their production
Grant 8,609,370 - Goletz , et al. December 17, 2
2013-12-17
Tumour cell lines and uses thereof
Grant 8,283,161 - Goletz , et al. October 9, 2
2012-10-09
Tumour Cell Lines and Uses Thereof
App 20110319590 - Goletz; Steffen ;   et al.
2011-12-29
Tumour cell lines and uses thereof
Grant 8,017,388 - Goletz , et al. September 13, 2
2011-09-13
Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies
App 20100028947 - Goletz; Steffen ;   et al.
2010-02-04
Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
Grant 7,595,192 - Goletz , et al. September 29, 2
2009-09-29
Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof
App 20060292129 - Goletz; Steffen ;   et al.
2006-12-28
Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
App 20060127419 - Goletz; Steffen ;   et al.
2006-06-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed